Contrafect Corp Stock Fundamentals
| CFRXDelisted Stock | USD 1.18 0.08 6.35% |
ContraFect Corp fundamentals help investors to digest information that contributes to ContraFect Corp's financial success or failures. It also enables traders to predict the movement of ContraFect Stock. The fundamental analysis module provides a way to measure ContraFect Corp's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to ContraFect Corp stock.
ContraFect |
ContraFect Corp Company Shares Outstanding Analysis
ContraFect Corp's Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.
Current ContraFect Corp Shares Outstanding | 10.7 M |
Most of ContraFect Corp's fundamental indicators, such as Shares Outstanding, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, ContraFect Corp is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
CompetitionBased on the latest financial disclosure, ContraFect Corp has 10.7 M of shares currently outstending. This is 94.07% lower than that of the Biotechnology sector and 89.98% lower than that of the Health Care industry. The shares outstanding for all United States stocks is 98.13% higher than that of the company.
ContraFect Corp Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining ContraFect Corp's current stock value. Our valuation model uses many indicators to compare ContraFect Corp value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across ContraFect Corp competition to find correlations between indicators driving ContraFect Corp's intrinsic value. More Info.ContraFect Corp is rated below average in return on equity category among its peers. It also is rated below average in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the ContraFect Corp's earnings, one of the primary drivers of an investment's value.ContraFect Shares Outstanding Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses ContraFect Corp's direct or indirect competition against its Shares Outstanding to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of ContraFect Corp could also be used in its relative valuation, which is a method of valuing ContraFect Corp by comparing valuation metrics of similar companies.ContraFect Corp is currently under evaluation in shares outstanding category among its peers.
ContraFect Fundamentals
| Return On Equity | -6.09 | |||
| Return On Asset | -1.17 | |||
| Current Valuation | (2.32 M) | |||
| Shares Outstanding | 10.7 M | |||
| Shares Owned By Insiders | 0.65 % | |||
| Shares Owned By Institutions | 6.13 % | |||
| Number Of Shares Shorted | 115.97 K | |||
| Price To Earning | 21.36 X | |||
| Price To Book | 0.44 X | |||
| Gross Profit | (1.61 M) | |||
| EBITDA | (30.05 M) | |||
| Net Income | (24.14 M) | |||
| Cash And Equivalents | 27.3 M | |||
| Cash Per Share | 0.69 X | |||
| Total Debt | 2.88 M | |||
| Debt To Equity | 0.24 % | |||
| Current Ratio | 1.83 X | |||
| Book Value Per Share | (0.54) X | |||
| Cash Flow From Operations | (35.59 M) | |||
| Short Ratio | 1.18 X | |||
| Earnings Per Share | (10.83) X | |||
| Target Price | 7.0 | |||
| Number Of Employees | 23 | |||
| Beta | 0.29 | |||
| Market Capitalization | 535.24 K | |||
| Total Asset | 20.68 M | |||
| Retained Earnings | (325.7 M) | |||
| Working Capital | (3.13 M) | |||
| Current Asset | 34.1 M | |||
| Current Liabilities | 3.77 M | |||
| Z Score | -26.92 | |||
| Net Asset | 20.68 M |
About ContraFect Corp Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze ContraFect Corp's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of ContraFect Corp using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of ContraFect Corp based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.ContraFect Corporation, a clinical-stage biotechnology company, discovers and develops therapeutic protein and antibody products for the treatment of life-threatening and drug-resistant infectious diseases in the United States. ContraFect Corporation was incorporated in 2008 and is headquartered in Yonkers, New York. Contrafect operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 38 people.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..
Other Consideration for investing in ContraFect Stock
If you are still planning to invest in ContraFect Corp check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the ContraFect Corp's history and understand the potential risks before investing.
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities |